Portal vein ligation and partial hepatectomy differentially influence growth of intrahepatic metastasis and liver regeneration in mice

Journal of Hepatology

Volumn 45, Issue 1, 2006, Pages 35-42

  Heinrich, Stefan ^a   Jochum, Wolfram ^a   Graf, Rolf ^a   Clavien, Pierre Alain ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Liver metastases; Liver regeneration; Lung metastases; Partial hepatectomy; Portal vein ligation; Tumor growth

Indexed keywords

ACTIVIN A; BROXURIDINE; CYCLINE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CELL STIMULATION; CELL STRAIN; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LIVER METASTASIS; LIVER REGENERATION; LUNG METASTASIS; MALE; MORPHOMETRICS; MOUSE; NONHUMAN; PARTIAL HEPATECTOMY; PORTAL VEIN; PRIORITY JOURNAL; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SYNTHESIS; VEIN LIGATION; VEIN OCCLUSION;

ANIMALS; CELL DIVISION; CELL LINE, TUMOR; COLONIC NEOPLASMS; DISEASE MODELS, ANIMAL; HEPATECTOMY; LIVER NEOPLASMS; LIVER REGENERATION; MALE; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS; PORTAL VEIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 33744899090     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2006.02.020     Document Type: Article

References (36)

1. Weitz J., Blumgart L., Fong Y., Jarnagin W., William R., D'Angela M., et al. Partial hepatectomy for metastases from noncolorectal, nonneuroendocrine carcinoma. Ann Surg 241 (2005) 269-276
2. Jarnagin W.R., Gonen M., Fong Y., DeMatteo R.P., Ben-Porat L., Little S., et al. Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg 236 (2002) 397-406 discussion 406-407
3. Petrowsky H., Gonen M., Jarnagin W., Lorenz M., DeMatteo R., Heinrich S., et al. Second liver resections are safe and effective treatment for recurrent hepatic metastases from colorectal cancer: a bi-institutional analysis. Ann Surg 235 (2002) 863-871
4. Scheele J., Stangl R., and Altendorf-Hofmann A. Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg 77 (1990) 1241-1246
5. Makuuchi M., Thai B.L., Takayasu K., Takayama T., Kosuge T., Gunven P., et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery 107 (1990) 521-527
6. Adam R., Laurent A., Azoulay D., Castaing D., and Bismuth H. Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors. Ann Surg 232 (2000) 777-785
7. Jaeck D., Oussoultzoglou E., Rosso E., Greget M., Weber J.C., and Bachellier P. A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg 240 (2004) 1037-1049 discussion 1049-1051
8. Kianmanesh R., Farges O., Abdalla E.K., Sauvanet A., Ruszniewski P., and Belghiti J. Right portal vein ligation: a new planned two-step all-surgical approach for complete resection of primary gastrointestinal tumors with multiple bilateral liver metastases. J Am Coll Surg 197 (2003) 164-170
9. Rous P., and Larimore L.D. Relation of the portal blood to liver maintenance. A demonstration of liver atrophy conditional on compensation. J Exp Med 31 (1920) 606-632
10. Takayasu K., Muramatsu Y., Shima Y., Moriyama N., Yamada T., and Makuuchi M. Hepatic lobar atrophy following obstruction of the ipsilateral portal vein from hilar cholangiocarcinoma. Radiology 160 (1986) 389-393
11. Abdalla E.K., Hicks M.E., and Vauthey J.N. Portal vein embolization: rationale, technique and future prospects. Br J Surg 88 (2001) 165-175
12. Azoulay D., Castaing D., Smail A., Adam R., Cailliez V., Laurent A., et al. Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg 231 (2000) 480-486
13. Elias D., De Baere T., Roche A., Mducreux, Leclere J., and Lasser P. During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma. Br J Surg 86 (1999) 784-788
14. de Jong K.P., Lont H.E., Bijma A.M., Brouwers M.A., de Vries E.G., van Veen M.L., et al. The effect of partial hepatectomy on tumor growth in rats: in vivo and in vitro studies. Hepatology 22 (1995) 1263-1272
15. Kokudo N., Tada K., Seki M., Ohta H., Azekura K., Ueno M., et al. Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization. Hepatology 34 (2001) 267-272
16. Picardo A., Karpoff H.M., Ng B., Lee J., Brennan M.F., and Fong Y. Partial hepatectomy accelerates local tumor growth: potential roles of local cytokine activation. Surgery 124 (1998) 57-64
17. Yokoyama H., Goto S., Chen C.L., Pan T.L., Kawano K., and Kitano S. Major hepatic resection may suppress the growth of tumours remaining in the residual liver. Br J Cancer 83 (2000) 1096-1101
18. Castillo M.H., Doerr R.J., Paolini Jr. N., Cohen S., and Goldrosen M. Hepatectomy prolongs survival of mice with induced liver metastases. Arch Surg 124 (1989) 167-169
19. Lafreniere R., and Rosenberg S.A. A novel approach to the generation and identification of experimental hepatic metastases in a murine model. J Natl Cancer Inst 76 (1986) 309-322
20. Higgins G., and Anderson R. Experimental pathology of the liver. Restoration of the liver of the white rat following partial surgical removal. Arch Path 12 (1931) 186-202
21. Michalopoulos G.K., and DeFrances M.C. Liver regeneration. Science 276 (1997) 60-66
22. Russell W.E., Coffey Jr. R.J., Ouellette A.J., and Moses H.L. Type beta transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. Proc Natl Acad Sci USA 85 (1988) 5126-5130
23. Fisher B., Szuch P., Levine M., and Fisher E.R. A portal blood factor as the humoral agent in liver regeneration. Science 171 (1971) 575-577
24. Moolten F.L., and Bucher N.L. Regeneration of rat liver: transfer of humoral agent by cross circulation. Science 158 (1967) 272-274
25. Lorenz M., Staib-Sebler E., Hochmuth K., Heinrich S., Gog C., Vetter G., et al. Surgical resection of liver metastases of colorectal carcinoma: short and long-term results. Semin Oncol 27 (2000) 112-119
26. de Jong K.P., Slooff M.J., de Vries E.G., Brouwers M.A., and Terpstra O.T. Effect of partial liver resection on tumour growth. J Hepatol 25 (1996) 109-121
27. Yokoyama H., Goto S., Chen C.L., Pan T.L., Kawano K., and Kitano S. Major hepatic resection may suppress the growth of tumours remaining in the residual liver. Br J Cancer 83 (2000) 1096-1101
28. Drixler T.A., Rinkes I.H., Ritchie E.D., van Vroonhoven T.J., Gebbink M.F., and Voest E.E. Continuous administration of angiostatin inhibits accelerated growth of colorectal liver metastases after partial hepatectomy. Cancer Res 60 (2000) 1761-1765
29. Slooter G.D., Marquet R.L., Jeekel J., and Ijzermans J.N. Tumour growth stimulation after partial hepatectomy can be reduced by treatment with tumour necrosis factor alpha. Br J Surg 82 (1995) 129-132
30. Loizidou M.C., Lawrance R.J., Holt S., Carty N.J., Cooper A.J., Alexander P., et al. Facilitation by partial hepatectomy of tumor growth within the rat liver following intraportal injection of syngeneic tumor cells. Clin Exp Metastasis 9 (1991) 335-349
31. Seglen P.O., Saeter G., and Schwarze P.E. Liver tumor promoters stimulate growth of transplanted hepatocellular carcinomas. Hepatology 12 (1990) 295-300
32. Slooter G.D., Aalbers A.G., Breeman W.A., Hiemstra C.A., Marquet R.L., Krenning E.P., et al. The inhibitory effect of (111)In-DTPA(0)-octreotide on intrahepatic tumor growth after partial hepatectomy. J Nucl Med 43 (2002) 1681-1687
33. Wildi S., Kleeff J., Maruyama H., Maurer C.A., Buchler M.W., and Korc M. Overexpression of activin A in stage IV colorectal cancer. Gut 49 (2001) 409-417
34. Tsushima H., Kawata S., Tamura S., Ito N., Shirai Y., Kiso S., et al. High levels of transforming growth factor beta 1 in patients with colorectal cancer: association with disease progression. Gastroenterology 110 (1996) 375-382
35. Derynck R., Akhurst R.J., and Balmain A. TGF-beta signaling in tumor suppression and cancer progression. Nat Genet 29 (2001) 117-129
36. Oe S., Lemmer E.R., Conner E.A., Factor V.M., Leveen P., Larsson J., et al. Intact signaling by transforming growth factor beta is not required for termination of liver regeneration in mice. Hepatology 40 (2004) 1098-1105